Multidrug Resistance in <i>Escherichia coli</i> Strains Isolated from Infections in Dogs and Cats in Poland (2007–2013)

Rzewuska, Magdalena; Czopowicz, Michał; Kizerwetter-Świda, Magdalena; Chrobak, D.; Blaszczak, B.; Binek, M.

doi:10.1155/2015/408205

Cited by 55 publications

(65 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Isolation of diarrhoeagenic antimicrobial-resistant E. coli from dogs with or without diarrhoea and/or their handlers have been reported in countries such as Italy (Carattoli et al 2005), Portugal (Costa et al 2008, Bien et al 2011, Poland (Rzewuska et al 2015), Brazil (de Almeida et al 2012, Paula and Marin 2008, Paula and Marin 2009, Siqueira et al 2009, Puno-Sarmiento et al 2013, the Netherlands (Ewers et al 2010, Ewers et al 2012, Argentina (Bentancor et al 2007), America (Shaheen et al 2011), and Egypt (Ali andMetwaly 2015, Yunis et al 2015). In the available literature, studies on pathogenic E. coli in diarrhoeic and/or healthy dogs in Iran include the reports of Zahrei Salehi et al (2011) and Koochakzadeh et al (2014).…”

Section: Introductionmentioning

confidence: 99%

Detection of virulence and antimicrobial resistance genes in Escherichia coli isolates from diarrhoiec dogs in Iran

Torkan¹,

Bahadoranian²,

Khamesipour³

et al. 2016

Arch. med. vet.

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Detection of virulence and antimicrobial resistance genes in Escherichia coli isolates from diarrhoiec dogs in Iran

Torkan¹,

Bahadoranian²,

Khamesipour³

et al. 2016

Arch. med. vet.

View full text Add to dashboard Cite

“…Resistance to three or more classes of antibacterial agent implies multidrug resistance (Tenover 2006;Nam et al, 2010;Rzewuska et al, 2015). In this study, resistance of all the Salmonella isolates to three or more of the antibacterial agents suggested that isolates in the genus exhibited higher multidrug resistance when compared with the multidrug resistance of the E. coli (81.8%) and Klebsiella (70%) isolates.…”

Section: Referencesmentioning

confidence: 61%

“…It is also higher than 16, 7, 6.6 and 2.6% ESBL-resistant/producing E. coli isolation prevalence in 100 extra-clinical faecal samples of dogs in Germany (Schaufler et al, 2015), among 445 clinical E. coli isolates from companion animals in United Kingdom (UK) (Timofte et al, 2016), faecal samples of 75 healthy dogs/cats (Costa et al, 2004) and 39 healthy dogs (Costa et al, 2008) reported in Portugal, respectively. Pomba et al (2009), Tamang et al (2012, Rzewuska et al (2015), Caratolli et al (2005), O'Keefe et al (2010), Huber et al (2013) and Feira et al (2002) reported 1.6, 2.9, 28.2, 7, 5, 7.5 and 1.4% ESBLproducing/resistant E. coli isolation prevalence among 61, 730, 628, 298, 257, 107 and 72 E. coli isolates from urine/urinary tract of sick dogs in Portugal, dogs/cats in Poland, intestinal E. coli isolates from stray dogs in South Korea, sick/healthy dogs/cats/rat in Italy, urine/urinary tract of sick dogs/cats in America and Switzerland, and healthy dogs in Portugal, respectively. These results are also lower than 40.7% E. coli isolation prevalence recorded in the current study.…”

Section: Discussionmentioning

confidence: 99%

“…There have been calls for assessment of companion animals as potential reservoirs and disseminators of ESBL-resistant organisms Weiler et al, 2011;Cozma et al, 2015a). Since the first report on isolation of ESBL-resistant E. coli in faecal sample of a laboratory dog in Japan (Matsumoto et al, 1998), improvements have been made on isolation of ESBL-resistant enterobacteria from clinical samples of dogs worldwide (Feria et al, 2002;Lim et al, 2009;Gibbson et al, 2010;O'Keefe et al, 2010;Timofte et al, 2011;Shaheen et al, 2011;Huber et al, 2013;Dierikx et al, 2012;Weiler et al, 2014;Rzewuska et al, 2015). Evidences support zoonotic transmission of ESBL-resistant enterobacteria from companion animals to humans and vice versa (Weiler et al, 2011;Meyer et al, 2012;Rubin and Pitout, 2014;Carvalho et al, 2016;Ljungquist et al, 2016).…”

Section: Isolation and Generic Identification Of Esbl-resistant Entermentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and Antibiogram of Generic Extended-Spectrum β-Lactam-Resistant Enterobacteria in Healthy Dogs

Anyanwu¹,

Ugwu²,

EZEKWELU³

et al. 2017

Not Sci Biol

View full text Add to dashboard Cite

This study was conducted to isolate generic extended-spectrum β-lactam-resistant enterobacteria from household dogs in Nigeria, and to determine the antibacterial resistance profile of the isolates. Rectal swabs were collected from 100, randomly selected, apparently healthy household dogs. Isolation of ESBL-resistant enterobacteria was done using Mac Conkey agar supplemented with 4 µg/ml of ceftazidime. Phenotypic characterization of the isolates to generic level was done following standard biochemical methods. Phenotypic resistance of the isolates to antibacterial agents was determined using the disc diffusion method. Out of 27 ESBL-resistant enterobacterial isolates, 40.7% were Escherichia coli, 37% were Klebsiella species, 18.5% were Salmonella species, while 3.7% was Proteus species. Resistance of the E. coli isolates was 81.8% to ampicillin, 27.2% to streptomycin, 54.5% to ciprofloxacin and tetracycline, 45.4% to enrofloxacin, 90.9% to sulphamethoxazole/trimethoprim, 9.1% to amoxicillin/clavulanic acid and 0% resistant to gentamicin. Resistance of the Klebsiella isolates was 80% to ampicillin, 20% to streptomycin and amoxicillin/clavulanic acid, 30% to ciprofloxacin and enrofloxacin, 60% to tetracycline, 90% to sulphamethoxazole/trimethoprim and 10% to gentamicin. Resistance of the Salmonella isolates was 100% to sulphamethoxazole/trimethoprim, 80% to gentamicin and ampicillin, 60% to streptomycin and tetracycline, 20% to amoxicillin/clavulanic acid, and 0% to ciprofloxacin and enrofloxacin. The Proteus isolate was resistant to streptomycin and gentamycin. All the isolates were resistant to ceftazidime and cefotaxime. Resistance of the isolates to more than 3 classes of antibacterial agents tested was 81.8% for E. coli, 70% for Klebsiella and 100% for Salmonella, respectively. This study has shown that household dogs in Nigeria, are colonized by ESBL-resistant Enterobacteriaceae and are potential reservoirs and disseminators of these organisms.

show abstract

“…One concerning trend documented in recent years has been the increased prevalence of nonsusceptibility to antimicrobials observed in canine urinary tract isolates, in particular to fluoroquinolones, third generation cephalosporins, and clavulanic acid-potentiated β-lactams (Cooke et al, 2002;Mazzuli, 2002;Ball et al, 2008;Sidjabat et al, 2009;Platell et al, 2011a;Hall et al, 2013;Wagner et al, 2014;Chang et al, 2015;Rzewuska et al, 2015). The availability of many of these drugs in oral forms that reach high concentrations in the urine following absorption, along with their efficacy against Gram-negative pathogens in particular, has resulted in their widespread use in companion animals.…”

Section: Observations Of Increasing Antimicrobial Resistance In Caninmentioning

confidence: 99%

Preventing canine urinary tract infection (UTI) using an asymptomatic bacteriuria (ASB) Escherichia coli strain

Thompson¹

View full text Add to dashboard Cite

Bacterial cystitis occurs with reasonable frequency in dogs. Persistent infection and repeated reinfection (recurrent bacterial urinary tract infection, hereafter termed recurrent UTI) is reported less frequently. Recurrent urinary tract infection is predominantly diagnosed in dogs with a predisposing or comorbid condition, and episodes are often subclinical. Escherichia coli is the most frequently cultured species in both uncomplicated bacterial cystitis and recurrent UTI.Antimicrobial therapy limitations and global emergence of bacterial strains that are both virulent and multidrug-resistant (MDR) has led to an urgent requirement for novel control strategies in both companion animals and humans. Escherichia coli strain 83972 has been successfully used to colonise the bladder of humans with recurrent UTI in order to reduce the incidence of subsequent febrile UTI via the process of active bacterial interference. This strategy has not been utilised in dogs to date but may prove an effective alternative to antimicrobial therapy if it can be shown to colonise the bladder of dogs safely and effectively compete with uropathogens.A retrospective study to examine the signalment, infecting strains, presence of clinical signs, and incidence of pyuria in Australian dogs with recurrent urinary tract infection was performed. The findings were similar to those of two large North-American studies with regard to signalment, predisposing or comorbid diseases, bacterial species isolated, and resistance to commonly used oral antimicrobials, although the median age of our dogs was higher at 10 years (7 years in both prior studies). Examination of the E. coli isolates from a subset of nine dogs provided new information on phylogenetic group, virulence gene profiles, haemolytic phenotype, expression of type 1 fimbriae, and sequence type (ST). Phylogenetic groups F and B2 were frequently identified, representing 13/32 (41%) and 8/32 (25%) of isolates respectively, but no phylogroup B2 isolates were MDR, in comparison with phylogroup F isolates, which accounted for 12/16 (75%) MDR isolates. Clonal groups of global importance such as ST131-B2, ST354-F, ST38-D and ST457-F were represented, with possible implications for both companion animal and human health. Of particular concern was the repeated isolation of ST354-F strains from the urine of a paralysed dog over a 3-year period.When competition experiments between E. coli 83972 and a selection of canine uropathogenic E. coli (UPEC), including emerging, highly virulent MDR strains with zoonotic potential, were performed in pooled canine urine, E. coli 83972 was largely non-competitive against the canine isolates after 17 hr of incubation. This finding contrasted with the competitive superiority previously exhibited by E. coli 83972 in pooled human urine in competition experiments with human UPEC strains. In 5/10 trials, the E. coli 83972 was not outcompeted in canine urine, iii however, and given that the starting ratio in dogs following prophylactic bladder colonisation would ...

show abstract

Multidrug Resistance in Escherichia coli Strains Isolated from Infections in Dogs and Cats in Poland (2007–2013)

Cited by 55 publications

References 33 publications

Detection of virulence and antimicrobial resistance genes in Escherichia coli isolates from diarrhoiec dogs in Iran

Detection of virulence and antimicrobial resistance genes in Escherichia coli isolates from diarrhoiec dogs in Iran

Prevalence and Antibiogram of Generic Extended-Spectrum β-Lactam-Resistant Enterobacteria in Healthy Dogs

Preventing canine urinary tract infection (UTI) using an asymptomatic bacteriuria (ASB) Escherichia coli strain

Contact Info

Product

Resources

About